Bank of Nova Scotia
MRVI icon

Bank of Nova Scotia’s Maravai LifeSciences MRVI Stock Holding History

Bank of Nova Scotia’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-159,495
Closed -$2.23M – 1109
2023
Q1 		$2.23M Sell
159,495
-139,355
-47% -$2M 0.01% 514
2022
Q4 		$4.28M Buy
298,850
+256,850
+612% +$4.04M 0.01% 495
2022
Q3 		$1.07M Sell
42,000
-106
-0.3% -$2.66K ﹤0.01% 777
2022
Q2 		$1.19M Buy
+42,106
New +$1.33M ﹤0.01% 812
2021
Q4 		– Sell
-210,900
Closed -$10.2M – 1261
2021
Q3 		$10.2M Buy
+210,900
New +$10.3M 0.02% 473

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of Nova Scotia's MRVI Position: Q2 2023 in Review

Bank of Nova Scotia sold out of Maravai LifeSciences (MRVI) in Q2 2023, closing a stake of 159,495 shares — an estimated $2.23M sold.

Bank of Nova Scotia first reported a position in MRVI in Q3 2021 and held it in 5 quarters. The position peaked at $10.2M in Q3 2021. 221 funds tracked by Wall St. Rank hold MRVI as of Q2 2023.

  • Bank of Nova Scotia reported no remaining Maravai LifeSciences position as of Q2 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 159,495 Maravai LifeSciences shares in Q2 2023, an estimated $2.23M.
  • Bank of Nova Scotia first reported a position in Maravai LifeSciences in Q3 2021 and held it in 5 quarters.
  • Bank of Nova Scotia's Maravai LifeSciences position peaked at $10.2M in Q3 2021.
  • 221 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2023.

Based on Bank of Nova Scotia's 13F filing for Q2 2023, filed 3 Aug 2023.